{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:56:02Z","timestamp":1760550962452,"version":"3.37.3"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Biol Eng Comput"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s11517-019-02038-2","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T12:02:48Z","timestamp":1570449768000},"page":"2483-2515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["GSIAR: gene-subcategory interaction-based improved deep representation learning for breast cancer subcategorical analysis using gene expression, applicable for precision medicine"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1563-9304","authenticated-orcid":false,"given":"Chiranjib","family":"Sur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"issue":"7605","key":"2038_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","volume":"534","author":"P Mertins","year":"2016","unstructured":"Mertins P, Mani DR, Ruggles KV, Gillette MA, Clauser KR, Wang P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534(7605):55\u201362","journal-title":"Nature"},{"issue":"7","key":"2038_CR2","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/sim.1668","volume":"23","author":"J Tyrer","year":"2004","unstructured":"Tyrer J, Stephen WD, Jack C (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23(7):1111\u20131130","journal-title":"Stat Med"},{"issue":"3","key":"2038_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1148\/radiology.196.3.7644649","volume":"196","author":"JA Baker","year":"1995","unstructured":"Baker JA, et al. (1995) Breast cancer: prediction with artificial neural network based on BI-RADS standardized lexicon. Radiology 196(3):817\u2013822","journal-title":"Radiology"},{"issue":"14","key":"2038_CR4","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1158\/1078-0432.CCR-04-2424","volume":"11","author":"SR Lakhani","year":"2005","unstructured":"Lakhani SR, et al. (2005) Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 11(14):5175\u20135180","journal-title":"Clin Cancer Res"},{"issue":"9381","key":"2038_CR5","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0140-6736(03)14023-8","volume":"362","author":"JC Chang","year":"2003","unstructured":"Chang JC, et al. (2003) Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. The Lancet 362(9381):362\u2013369","journal-title":"The Lancet"},{"issue":"16","key":"2038_CR6","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","volume":"65","author":"MV Iorio","year":"2005","unstructured":"Iorio MV, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65 (16):7065\u20137070","journal-title":"Cancer Res"},{"issue":"10","key":"2038_CR7","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1200\/JCO.2003.09.099","volume":"21","author":"V Bardou","year":"2003","unstructured":"Bardou V, et al. (2003) Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol 21 (10):1973\u20131979","journal-title":"J Clin Oncol"},{"issue":"8","key":"2038_CR8","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"J Parker","year":"2009","unstructured":"Parker J, et al. (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27(8):1160\u20131167","journal-title":"J Clin Oncol"},{"issue":"11","key":"2038_CR9","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1200\/JCO.2009.24.4798","volume":"28","author":"M Dowsett","year":"2010","unstructured":"Dowsett M, et al. (2010) Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study. J Clin Oncol 28(11):1829\u20131834","journal-title":"J Clin Oncol"},{"issue":"16","key":"2038_CR10","first-page":"5979","volume":"61","author":"S Gruvberger","year":"2001","unstructured":"Gruvberger S, et al. (2001) Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 61(16):5979\u20135984","journal-title":"Cancer Res"},{"issue":"9805","key":"2038_CR11","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/S0140-6736(11)61539-0","volume":"378","author":"J Reis-Filho","year":"2011","unstructured":"Reis-Filho J, Lajos P (2011) Gene expression profiling in breast cancer: classification, prognostication, and prediction. The Lancet 378(9805):1812\u20131823","journal-title":"The Lancet"},{"issue":"4","key":"2038_CR12","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1287\/opre.43.4.570","volume":"43","author":"O Mangasarian","year":"1995","unstructured":"Mangasarian O, Street W, Wolberg W (1995) Breast cancer diagnosis and prognosis via linear programming. Oper Res 43(4):570\u2013577","journal-title":"Oper Res"},{"issue":"20","key":"2038_CR13","doi-asserted-by":"publisher","first-page":"11462","DOI":"10.1073\/pnas.201162998","volume":"98","author":"M West","year":"2001","unstructured":"West M, et al. (2001) Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci 98(20):11462\u201311467","journal-title":"Proc Natl Acad Sci"},{"issue":"789","key":"2038_CR14","first-page":"378","volume":"6559","author":"R Wooster","year":"1995","unstructured":"Wooster R, et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 6559(789):378","journal-title":"Nature"},{"issue":"25","key":"2038_CR15","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1056\/NEJMoa021967","volume":"347","author":"V Van","year":"2002","unstructured":"Van V, Marc J, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347(25):1999\u20132009","journal-title":"N Engl J Med"},{"issue":"7050","key":"2038_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"A Minn","year":"2005","unstructured":"Minn A, et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436(7050):518\u2013524","journal-title":"Nature"},{"issue":"23","key":"2038_CR17","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1200\/JCO.2005.04.7985","volume":"24","author":"S Paik","year":"2006","unstructured":"Paik S, et al. (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor\u2013positive breast cancer. J Clin Oncol 24(23):3726\u20133734","journal-title":"J Clin Oncol"},{"issue":"9369","key":"2038_CR18","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0140-6736(03)13308-9","volume":"361","author":"E Huang","year":"2003","unstructured":"Huang E, et al. (2003) Gene expression predictors of breast cancer outcomes. The Lancet 361(9369):1590\u20131596","journal-title":"The Lancet"},{"issue":"2","key":"2038_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/path.2648","volume":"220","author":"B Weigelt","year":"2010","unstructured":"Weigelt B, Frederick B, Jorge R (2010) The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J Pathol 220(2):263\u2013280","journal-title":"J Pathol"},{"issue":"2","key":"2038_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/path.2407","volume":"21","author":"B Weigelt","year":"2008","unstructured":"Weigelt B, et al. (2008) Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 21(2):141\u2013150","journal-title":"J Pathol"},{"issue":"18","key":"2038_CR21","doi-asserted-by":"publisher","first-page":"10393","DOI":"10.1073\/pnas.1732912100","volume":"100","author":"C Sotiriou","year":"2003","unstructured":"Sotiriou C, et al. (2003) Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci 100(18):10393\u201310398","journal-title":"Proc Natl Acad Sci"},{"issue":"8-9","key":"2038_CR22","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/0959-8049(92)90534-9","volume":"28","author":"C Axelsson","year":"1992","unstructured":"Axelsson C, et al. (1992) Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur J Cancer 28(8-9):1415\u20131418","journal-title":"Eur J Cancer"},{"issue":"140","key":"2038_CR23","first-page":"3","volume":"1","author":"H Chuang","year":"2007","unstructured":"Chuang H, et al. (2007) Network-based classification of breast cancer metastasis. Mol Syst Biol 1(140):3","journal-title":"Mol Syst Biol"},{"issue":"29","key":"2038_CR24","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.1200\/JCO.2005.03.3845","volume":"23","author":"J Brenton","year":"2005","unstructured":"Brenton J, et al. (2005) Molecular classification and molecular forecasting of breast cancer: ready for clinical application?. J Clin Oncol 23(29):7350\u20137360","journal-title":"J Clin Oncol"},{"issue":"9460","key":"2038_CR25","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(05)17947-1","volume":"365","author":"Y Wang","year":"2005","unstructured":"Wang Y, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. The Lancet 365(9460):671\u2013679","journal-title":"The Lancet"},{"issue":"suppl_10","key":"2038_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/annonc\/mds326","volume":"23","author":"G Viale","year":"2012","unstructured":"Viale G (2012) The current state of breast cancer classification. Ann Oncol 23(suppl_10):207\u2013210","journal-title":"Ann Oncol"},{"issue":"212","key":"2038_CR27","first-page":"13","volume":"3","author":"P Colombo","year":"2011","unstructured":"Colombo P, et al. (2011) Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction. Breast Cancer Res 3(212):13","journal-title":"Breast Cancer Res"},{"issue":"207","key":"2038_CR28","first-page":"12","volume":"4","author":"A Rakha","year":"2010","unstructured":"Rakha A, et al. (2010) Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res 4(207):12","journal-title":"Breast Cancer Res"},{"key":"2038_CR29","unstructured":"Tan A, Gilbert D (2003) Ensemble machine learning on gene expression data for cancer classification"},{"issue":"1","key":"2038_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1023\/A:1012487302797","volume":"46","author":"I Guyon","year":"2002","unstructured":"Guyon I, et al. (2002) Gene selection for cancer classification using support vector machines. Mach Learn 46(1):389\u2013422","journal-title":"Mach Learn"},{"issue":"2","key":"2038_CR31","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1016\/j.eswa.2008.01.009","volume":"36","author":"M Akay","year":"2009","unstructured":"Akay M (2009) Support vector machines combined with feature selection for breast cancer diagnosis. Expert systems with applications 36(2):3240\u20133247","journal-title":"Expert systems with applications"},{"issue":"4","key":"2038_CR32","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.dsp.2006.10.008","volume":"17","author":"K Polat","year":"2007","unstructured":"Polat K, Gunes S (2007) Breast cancer diagnosis using least square support vector machine. Digital Signal Process 17(4):694\u2013701","journal-title":"Digital Signal Process"},{"issue":"1","key":"2038_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/1471-2105-9-319","volume":"9","author":"A Statnikov","year":"2008","unstructured":"Statnikov A, Wang L, Constantin A (2008) A comprehensive comparison of random forests and support vector machines for microarray-based cancer classification. BMC Bioinf 9(1):319","journal-title":"BMC Bioinf"},{"key":"2038_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/117693510600200030","volume":"2","author":"A Cruz","year":"2006","unstructured":"Cruz A, David W (2006) Applications of machine learning in cancer prediction and prognosis. Cancer Informat 2:59","journal-title":"Cancer Informat"},{"key":"2038_CR35","unstructured":"Xin J et al (2006) Machine learning techniques and chi-square feature selection for cancer classification using SAGE gene expression profiles. International Workshop on Data Mining for Biomedical Applications"},{"issue":"2","key":"2038_CR36","first-page":"77","volume":"17","author":"W Wolberg","year":"1995","unstructured":"Wolberg W, Street W, Mangasarian O (1995) Image analysis and machine learning applied to breast cancer diagnosis and prognosis. Anal Quant Cytol Histol 17(2):77\u201387","journal-title":"Anal Quant Cytol Histol"},{"issue":"3","key":"2038_CR37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1109\/TMI.2004.842457","volume":"24","author":"L Wei","year":"2005","unstructured":"Wei L, et al. (2005) A study on several machine-learning methods for classification of malignant and benign clustered microcalcifications. IEEE Trans Med Imaging 24(3):371\u2013380","journal-title":"IEEE Trans Med Imaging"},{"key":"2038_CR38","unstructured":"Murphy K (2006) Naive bayes classifiers. University of British Columbia"},{"key":"2038_CR39","unstructured":"Scott M (2002) Applied logistic regression analysis. Vol. 106. Sage"},{"issue":"3","key":"2038_CR40","first-page":"18","volume":"2","author":"A Liaw","year":"2002","unstructured":"Liaw A, Wiener M (2002) Classification and regression by random forest. R news 2(3):18\u201322","journal-title":"R news"},{"issue":"3","key":"2038_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1023\/A:1018628609742","volume":"9","author":"J Suykens","year":"1999","unstructured":"Suykens J, Vandewalle J (1999) Least squares support vector machine classifiers. Neural Process Lett 9 (3):293\u2013300","journal-title":"Neural Process Lett"},{"key":"2038_CR42","unstructured":"http:\/\/www.breastcancer.org\/symptoms\/understand_bc\/statistics"},{"issue":"1","key":"2038_CR43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/hex.12832","volume":"22","author":"E Ross","year":"2019","unstructured":"Ross E, et al. (2019) Online accounts of gene expression profiling in early-stage breast cancer: interpreting genomic testing for chemotherapy decision making. Health Expect 22(1):74\u201382","journal-title":"Health Expect"},{"key":"2038_CR44","doi-asserted-by":"crossref","unstructured":"Srour MK et al (2019) Gene expression comparison between primary triple-negative breast cancer and matched axillary lymph node metastasis: 565-565","DOI":"10.1200\/JCO.2019.37.15_suppl.565"},{"issue":"9","key":"2038_CR45","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1158\/1078-0432.CCR-18-3427","volume":"25","author":"Harikrishna Nakshatri","year":"2019","unstructured":"Nakshatri Harikrishna, et al. (2019) Genetic ancestry\u2013dependent differences in breast cancer\u2013induced field defects in the tumor-adjacent normal breast. Clin Cancer Res 25(9):2848\u20132859","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2038_CR46","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12885-019-5554-z","volume":"19","author":"CD Savci-Heijink","year":"2019","unstructured":"Savci-Heijink CD, et al. (2019) A specific gene expression signature for visceral organ metastasis in breast cancer. BMC Cancer 19(1):333","journal-title":"BMC Cancer"},{"issue":"1","key":"2038_CR47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccell.2018.12.002","volume":"35","author":"D Ishay-Ronen","year":"2019","unstructured":"Ishay-Ronen D, et al. (2019) Gain fat\u2014lose metastasis: converting invasive breast cancer cells into adipocytes inhibits cancer metastasis. Cancer Cell 35(1):17\u201332","journal-title":"Cancer Cell"},{"issue":"1","key":"2038_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12885-018-5262-0","volume":"19","author":"R Mechera","year":"2019","unstructured":"Mechera R, et al. (2019) Expression of RET is associated with Oestrogen receptor expression but lacks prognostic significance in breast cancer. BMC Cancer 19(1):41","journal-title":"BMC Cancer"},{"key":"2038_CR49","doi-asserted-by":"crossref","unstructured":"Liedtke C, Pusztai L (2019) Gene expression profiling as an emerging diagnostic tool to personalize chemotherapy selection for early stage breast cancer. Pharmacogenetics of Breast Cancer. CRC Press, pp 87\u2013106","DOI":"10.3109\/9781420052947-9"},{"issue":"2019","key":"2038_CR50","first-page":"38","volume":"15","author":"G Paroni","year":"2675","unstructured":"Paroni G, et al. (2675) HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases. Oncogene 15(2019):38","journal-title":"Oncogene"},{"key":"2038_CR51","doi-asserted-by":"crossref","unstructured":"Chang JC, Hilsenbeck SG, Fuqua AW (2019) Pharmacogenetics of breast cancer: toward the individualization of therapy. Pharmacogenetics of Breast Cancer. CRC Press, pp 15\u201323","DOI":"10.3109\/9781420052947-4"},{"key":"2038_CR52","doi-asserted-by":"crossref","unstructured":"Dworkin AM, Huang TH-M, Toland AE (2019) The role of epigenetics in breast cancer: implications for diagnosis, prognosis, and treatment. Pharmacogenetics of breast cancer. CRC Press, pp 57\u201371","DOI":"10.3109\/9781420052947-7"},{"key":"2038_CR53","unstructured":"Asano Yuka, et al. (2018) Expression and clinical significance of androgen receptor in triple-negative breast cancer. AR Signaling in Human Malignancies: Prostate Cancer and Beyond, pp 197"},{"issue":"2","key":"2038_CR54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1101\/gr.226019.117","volume":"28","author":"HL Franco","year":"2018","unstructured":"Franco HL, et al. (2018) Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis. Genome Res 28(2):159\u2013170","journal-title":"Genome Res"},{"issue":"8","key":"2038_CR55","first-page":"2018","volume":"118","author":"B Gyorffy","year":"1107","unstructured":"Gyorffy B, et al. (1107) An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes. Br J Cancer 118(8):2018","journal-title":"Br J Cancer"},{"issue":"10","key":"2038_CR56","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nrclinonc.2017.74","volume":"14","author":"M Kwa","year":"2017","unstructured":"Kwa M, Makris A, Esteva FJ (2017) Clinical utility of gene-expression signatures in early stage breast cancer. Nat Rev Clin Oncol 14(10):595","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"2038_CR57","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1158\/0008-5472.CAN-16-2717","volume":"77","author":"JM Cejalvo","year":"2017","unstructured":"Cejalvo JM, et al. (2017) Intrinsic subtypes and gene expression profiles in primary and metastatic breast cancer. Cancer Res 77(9):2213\u20132221","journal-title":"Cancer Res"},{"issue":"1","key":"2038_CR58","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10549-017-4102-2","volume":"162","author":"R Ramanathan","year":"2017","unstructured":"Ramanathan R, et al. (2017) Angiopoietin pathway gene expression associated with poor breast cancer survival. Breast Cancer Res Treat 162(1):191\u2013198","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"2038_CR59","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1158\/1078-0432.CCR-16-0979","volume":"23","author":"I Bozovic-Spasojevic","year":"2017","unstructured":"Bozovic-Spasojevic I, et al. (2017) The prognostic role of androgen receptor in patients with early-stage breast cancer: a meta-analysis of clinical and gene expression data. Clin Cancer Res 23(11):2702\u20132712","journal-title":"Clin Cancer Res"},{"issue":"27","key":"2038_CR60","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1073\/pnas.1618706114","volume":"114","author":"F Casciello","year":"2017","unstructured":"Casciello F, et al. (2017) G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis. Proc Natl Acad Sci 114(27):7077\u20137082","journal-title":"Proc Natl Acad Sci"},{"issue":"10087","key":"2038_CR61","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/S0140-6736(16)32454-0","volume":"389","author":"C Denkert","year":"2017","unstructured":"Denkert C, et al. (2017) Molecular alterations in triple-negative breast cancer\u2014the road to new treatment strategies. The Lancet 389(10087):2430\u20132442","journal-title":"The Lancet"},{"issue":"16","key":"2038_CR62","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.7150\/jca.18457","volume":"8","author":"X Dai","year":"2017","unstructured":"Dai X, et al. (2017) Breast cancer cell line classification and its relevance with breast tumor subtyping. J Cancer 8(16):3131","journal-title":"J Cancer"}],"container-title":["Medical &amp; Biological Engineering &amp; Computing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11517-019-02038-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11517-019-02038-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11517-019-02038-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T09:05:26Z","timestamp":1650099926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11517-019-02038-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,7]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2038"],"URL":"https:\/\/doi.org\/10.1007\/s11517-019-02038-2","relation":{},"ISSN":["0140-0118","1741-0444"],"issn-type":[{"type":"print","value":"0140-0118"},{"type":"electronic","value":"1741-0444"}],"subject":[],"published":{"date-parts":[[2019,10,7]]},"assertion":[{"value":"25 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by the author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical approval"}}]}}